NIH-funded research R01 grant

Smart Eye Emulator to understand glaucoma risk

Official title: SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factors

Funded at University of Maine Orono · NIH-11182599 · Data updated 2026-11-12

This project builds a computer 'eye emulator' to explain how eye pressure, blood pressure, age, and race influence glaucoma risk for people with or at risk for open-angle glaucoma.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maine Orono
NIH-funded
Lab location1 site (Orono, United States)
Project startSeptember 1, 2022
Project endJune 30, 2026
Funding year2025
Award (this year)$217,817
NIH project number5R01EY034718-05
Project IDNIH-11182599 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with open-angle glaucoma or those considered at elevated risk who have recorded eye pressure and blood pressure measurements and who represent diverse ages and racial backgrounds.

Less likely to help

People with non–open-angle glaucoma types (for example, angle-closure or congenital glaucoma) or those with advanced, end-stage vision loss are unlikely to benefit from this risk-modeling approach.

What this research studies

If I share my eye and blood pressure measurements or clinical data, researchers will use a computer model that mimics eye biomechanics to see how intraocular pressure (IOP) and blood pressure (BP) interact in my case. They combine clinical measurements with age, gender, and race information to create a fast, patient-specific emulator that estimates weighted contributions of different risk factors. The team aims to produce a tool clinicians can use to personalize care—focusing treatment on those at highest risk while avoiding unnecessary interventions for low-risk patients. The work relies mainly on computer modeling and clinical data rather than testing new medications.

Why it matters

Potential benefit: If successful, this could help doctors tailor glaucoma treatment by identifying which patients truly need pressure-lowering therapy and which may be safely monitored.

How similar studies have gone: Prior research has linked blood pressure and intraocular pressure to glaucoma risk, but using a fast, individualized 'eye emulator' to weigh their relative contributions is a novel, translational approach.

Where this research is happening

  • University of Maine Orono
    Orono, United States
    Active

Researchers

  • Principal investigator: Guidoboni, Giovanna — University of Maine Orono
  • Study coordinator: Guidoboni, Giovanna

Related research

Other NIH-funded projects on the same topics.

  • IOP and CSF Pressure in Glaucoma Risk

    This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.

    NIH research University of Alabama at Birmingham · Birmingham, United States · NIH-11644421

  • IOP and CSF Pressure Factors in Glaucoma

    A patient-focused look at how eye pressure and surrounding fluid pressure may influence glaucoma risk and progression.

    NIH research University of Alabama at Birmingham · Birmingham, United States · NIH-11345220

  • How genes and everyday exposures affect risk of exfoliation syndrome and glaucoma

    Looks at whether genetic differences and common exposures like sunlight and coffee change the chance of exfoliation syndrome and related glaucoma for people at risk of vision loss.

    NIH research Massachusetts Eye and Ear Infirmary · Boston, United States · NIH-11138698

  • Understanding Eye and Brain Pressure in Glaucoma

    This research aims to better understand how pressure inside the eye and around the brain contributes to glaucoma and vision loss.

    NIH research University of Alabama at Birmingham · Birmingham, United States · NIH-11099939

  • Using a smart eye emulator to understand glaucoma risk factors

    This study is looking at what factors might increase the risk of open angle glaucoma, so we can create a smart tool to help doctors better understand who needs more attention and who might not need as much treatment, making it easier for everyone to get the right care.

    NIH research University of Maine Orono · Orono, United States · NIH-10930934

  • ALS risk factors in a long-term ALS study

    A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.

    NIH research Als Therapy Development Foundation · Watertown, United States · NIH-11631679

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.